Launch of RephiLe’s Genie in China
May 10, 2018
RephiLe held an impressive launch with designed preparation recently in China to welcome its new family member (Genie Water System). It split one Launch into three events respectively in March in Guangzhou, April in Beijing & May in Shanghai. On-site photos below bring you the passion attendees expressed in Genie. Launch events in [...]
New UV Monitor Kit for Large Scale Purification
May 10, 2018
Uppsala, Sweden -- Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of a new unique UV Monitor Kit which can be easily added to Biotage® Flash 150 and Biotage® Flash 400 systems in pharmaceutical development or manufacturing environments. The new UV Monitor Kit utilizes the [...]
BC Platforms partners with Sentieon to provide precision medicine solutions on a population scale
May 10, 2018
BC Platforms, a world leader in genomic data management and analysis solutions, today announces that it has partnered with Sentieon to integrate Sentieon’s award winning NGS data processing software into BC Platform’s highly scalable integrated genomics and clinical data solutions. This combination of technologies will provide an integrated system enabling highly accurate sample by sample [...]
May 10, 2018
BJS Biotechnologies Ltd and Techcomp signed an exclusive distribution agreement in May 2018. Techcomp will now represent and sell the xxpress® qPCR thermal cycler in China, Hong Kong and Taiwan. Techcomp is engaged in the design, development, manufacture and distribution of analytical instruments, life science equipment and laboratory instruments. Operations are grouped into 2 business [...]
Biotage and CEO Torben Jörgensen have agreed to extend period of service
May 9, 2018
Biotage’s Board of Directors and Torben Jörgensen have agreed to extend Torben Jörgensen’s current employment contract as Biotage’s CEO and President up and until April 2020 when Torben Jörgensen will be 68 years old. According to the previous contract, Torben Jörgensen would leave Biotage April 2019. About Biotage Biotage offers efficient separation technologies from analysis [...]
What is Hydrophobic Interaction Chromatography? The All-New BioPro HIC BF Column
May 9, 2018
If you are interested in learning more about our high-performance liquid chromatography products online, we encourage you to browse our website today. Continue below to learn about our new hydrophobic interaction chromatography (HIC) columns and how they can help improve your protein separations: What is HIC? The technique known as hydrophobic interaction chromatography (HIC) is a mode of [...]
CareDx expands NGS Transplant Product Offerings
May 9, 2018
License and Commercialization Agreement with Illumina BRISBANE, Calif. -- CareDx (NASDAQ:CDNA), today announced that, as reported in its Current Report on Form 8-K filed with the Securities Exchange Commission on May 8, 2018, it entered into a License and Commercialization Agreement with Illumina, Inc., which provides CareDx with worldwide distribution, development and commercialization rights to Illumina’s next generation sequencing (NGS) product line for [...]
May 9, 2018
Sunnyvale -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid Services (CMS), which oversees the Clinical Laboratory Improvement Amendments (CLIA) Program. Arrayit’s new CLIA license, issued in conjunction with the Department of Health and Human Services (HHS) and the [...]
May 9, 2018
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore and other parties of patent infringement litigation between the parties in the United Kingdom and Germany, under which Oxford Nanopore will refrain from offering “2D” sequencing products through the end [...]
VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits
May 9, 2018
ISNES, Belgium -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has entered into a Global Sales and Distribution Agreement with Active Motif for a range of Research Use Only ("RUO") kits, that are based on its proprietary Nucleosomics® technology. Founder and Chairman of Active Motif, Joseph M. Fernandez commented "We are continuously looking for innovative [...]
